Medical Marijuana Patients Don't Have Gun Rights: Federal Court Rules On Nikki Fried's Second Amendment Lawsuit

A Federal Court dismissed Nikki Fried’s Second Amendment lawsuit against the federal government seeking to allow medical marijuana patients to buy and own firearms.

US District Judge Allen Winsor wrote in the Friday ruling that “Florida’s medical marijuana users are ‘unlawful user[s] of . . . [a] controlled substance,’ so this law makes it a crime for them to possess firearms.” 

Fried is Florida’s agriculture and consumer services commissioner.

Background

Fried announced the litigation at the Benzinga Cannabis Capital Conference in Miami Beach on the 4/20 cannabis holiday.

The lawsuit argues that there is a conflict between state and federal law and that federal policy requires medical marijuana (MMJ) cardholders to choose between their state constitutional right to MMJ and their Second Amendment right.

“No patient should have to choose between medicine and employment, a roof over their head, access to capital or their Constitutional rights,” Fried said adding that the country's marijuana policies are “irrational, inconsistent, and incoherent.”

Fried, a medical marijuana cardholder and gun owner, explained that MMJ patients face felony charges if they lie about their marijuana use on a federal firearm application.

In July, Fried’s lawyers and other plaintiffs argued that under the recent SCOTUS ruling, the current federal policy banning those who admit to using marijuana in a background check could not be enforced.

In August, the DOJ asked a federal court to dismiss Fried’s lawsuit, arguing it would be too “dangerous to trust regular marijuana users to exercise sound judgment.”

Fried stated that she was disappointed that the DOJ decided to “double down on harmful prohibition policies. DOJ’s argument is as offensive as it is inaccurate." 

“I will never stop looking for outside-the-box ways we can further this fight until we achieve full and equitable legalization,” Fried said at the time.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Dismissal Highlights 

Now, several months after the DOJ urged a federal court to dismiss the lawsuit, the ruling came in, with the federal court siding with the DOJ. The core of the judge’s ruling lies in the argument that individuals who consume cannabis are engaging in illegal activity at the federal level, even though medical marijuana has been legalized at the state level. This makes for the precedent to refute their gun rights.

“Laws keeping guns from the mentally ill likewise flow from the historical tradition of keeping guns from those in whose hands they could be dangerous,” the judge wrote. “Plaintiffs recoil at being compared to the mentally ill…but one does not have to label marijuana users mentally ill to recognize that both categories of people can be dangerous when armed. Although the prohibition reaches those habitually using marijuana (even if not currently under the influence), habitual drug users are analogous to other groups the government has historically found too dangerous to have guns.”

Furthermore, Winsor explained that this right can be retrieved - “unlawful drug users can regain their Second Amendment rights by simply ending their drug use.”

Photo: Benzinga Edit; Sources: Popel Arseniy and IRA_EVVA by Shutterstock and Wikimedia Commons

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsDOJgun rightsNikki Fried
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.